peptide injections retatrutide Retatrutide 40mg Pen | Triple

Correct storage of retatrutide is essential to maintain the stability and efficacy of the medication

Measurable weight loss typically begins in weeks 24, with the most significant losses occurring between months 3 and 9 as the dose reaches therapeutic levels

And weeks 36 through 48 approached a plateau in most participants, with weight either stabilizing or declining very slowly

Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026 (Figure 1)

Sakai, Y

This peptide is prepared under controlled production standards to ensure consistent quality suitable for professional research environments